Related references
Note: Only part of the references are listed.Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon et al.
CLINICS IN GERIATRIC MEDICINE (2020)
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein
Yunden Jinsmaa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
The catecholaldehyde hypothesis: where MAO fits in
David S. Goldstein
JOURNAL OF NEURAL TRANSMISSION (2020)
Electroactive fluorescent false neurotransmitter FFN102 partially replaces dopamine in PC12 cell vesicles
Lihui Hu et al.
BIOPHYSICAL CHEMISTRY (2019)
Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters
Kevin G. Mulvihill
NEUROCHEMISTRY INTERNATIONAL (2019)
Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra
Edna Gruenblatt et al.
NEUROTOXICITY RESEARCH (2018)
Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein
Jonathan W. Werner-Allen et al.
BIOCHEMISTRY (2018)
Hydroxylated and sulfated metabolites of commonly observed airborne polychlorinated biphenyls display selective uptake and toxicity in N27, SH-SY5Y, and HepG2 cells
Eric A. Rodriguez et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2018)
3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine
Yunden Jinsmaa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Early adverse experience and substance addiction: dopamine, oxytocin, and glucocorticoid pathways
Sohye Kim et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
The SH-SY5Y cell line in Parkinson's disease research: a systematic review
Helena Xicoy et al.
MOLECULAR NEURODEGENERATION (2017)
Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity
Marieke Klein et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells
Fernanda M. Lopes et al.
NEUROTOXICITY RESEARCH (2017)
Comparison of different &ITin vitro&IT cell models for the assessment of pesticide-induced dopaminergic neurotoxicity
Harm J. Heusinkveld et al.
TOXICOLOGY IN VITRO (2017)
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
N. Plotegher et al.
SCIENTIFIC REPORTS (2017)
A Dopamine Hypothesis of Autism Spectrum Disorder
Denis Paval
DEVELOPMENTAL NEUROSCIENCE (2017)
An Integrative Perspective on the Role of Dopamine in Schizophrenia
Tiago V. Maia et al.
BIOLOGICAL PSYCHIATRY (2017)
Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde
Brigitte C. Vanle et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein
Jon W. Werner-Allen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite
David G. Anderson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Cellular models for Parkinson's disease
Bjoern H. Falkenburger et al.
JOURNAL OF NEUROCHEMISTRY (2016)
A kinome wide screen identifies novel kinases involved in regulation of monoamine transporter function
Anne Vuorenpaa et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model
Adhithiya Charli et al.
NEUROTOXICOLOGY (2016)
In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigra
Guohua Yu et al.
EXPERIMENTAL NEUROLOGY (2015)
Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease
David S. Goldstein et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and L-DOPA reversible motor deficits
S. T. Masoud et al.
NEUROBIOLOGY OF DISEASE (2015)
A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro
Sean L. Hammond et al.
NEUROSCIENCE LETTERS (2015)
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration
David S. Goldstein et al.
PARKINSONISM & RELATED DISORDERS (2015)
Vesicular expression and release of ATP from dopaminergic neurons of the mouse retina and midbrain
Tracy Ho et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
α-Synuclein Protects Against Manganese Neurotoxic Insult During the Early Stages of Exposure in a Dopaminergic Cell Model of Parkinson's Disease
Dilshan S. Harischandra et al.
TOXICOLOGICAL SCIENCES (2015)
Cell-based assays for Parkinson's disease using differentiated human LUHMES cells
Xiao-min Zhang et al.
ACTA PHARMACOLOGICA SINICA (2014)
Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease
Arthur G. Fitzmaurice et al.
NEUROLOGY (2014)
Cellular Localization of Dieldrin and Structure-Activity Relationship of Dieldrin Analogues in Dopaminergic Cells
Erin M. G. Allen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2013)
Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4
David N. Hauser et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease
David S. Goldstein et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain
Pamela C. Rodriguez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
Arthur G. Fitzmaurice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A molecular signature in blood identifies early Parkinson's disease
Leonid Molochnikov et al.
MOLECULAR NEURODEGENERATION (2012)
Disruption of spine homeostasis causes dopaminergic compensatory up-regulation, resulting in schizophrenia
Kohji Sato
MEDICAL HYPOTHESES (2012)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone
David G. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite
Lydia M. Mexas et al.
NEUROTOXICOLOGY (2011)
Differentiation of mouse Neuro 2A cells into dopamine neurons
Roger G. Tremblay et al.
JOURNAL OF NEUROSCIENCE METHODS (2010)
The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
W. Michael Panneton et al.
PLOS ONE (2010)
Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive Intermediate
Yunden Jinsmaa et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Dopamine Transporter Genetic Variants and Pesticides in Parkinson's Disease
Beate R. Ritz et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease
Teresa G. Hastings
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
Research Review: Dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD
Gail Tripp et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2008)
Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity
Susanne Jorgensen et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Kinetic and structural analysis of the early oxidation products of dopamine -: Analysis of the interactions with α-synuclein
Marco Bisaglia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system
Jaime M. Hatcher et al.
EXPERIMENTAL NEUROLOGY (2007)
5′ and 3′ region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk:: a hypothesis-generating study
Samir N. P. Kelada et al.
HUMAN MOLECULAR GENETICS (2006)
Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease
Jason R. Richardson et al.
FASEB JOURNAL (2006)
Differentiated dopaminergic MN9D cells only partially recapitulate the electrophysiological properties of midbrain dopaminergic neurons
C. E. Rick et al.
DEVELOPMENTAL NEUROSCIENCE (2006)
DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T α-synuclein toxicity
WB Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: Relationships with 3,4-dihydroxyphenylacetaldehyde formation
H Legros et al.
NEUROTOXICOLOGY (2004)
The vesicular amine transporter family (SLC18):: amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine
LE Eiden et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Share Paper
